After receiving @days of rivaroxaban @mg twice daily to obtain supratherapeutic steady-state concentrations , volunteers were randomized to receive a single @IUkg ( -@ ) bolus dose of four-factor PCC , three-factor PCC or saline @h after the morning dose of rivaroxaban on day@ , and the effects of these interventions on prothrombin time and thrombin generation were determined .